FA
GH icon

FDx Advisors’s Guardant Health GH Stock Holding History

FDx Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,331
Closed -$233K – 756
2022
Q3 		$233K Sell
4,331
-1,045
-19% -$53.6K 0.01% 644
2022
Q2 		$217K Buy
5,376
+821
+18% +$40.7K 0.01% 751
2022
Q1 		$302K Sell
4,555
-716
-14% -$49K 0.01% 661
2021
Q4 		$527K Sell
5,271
-270
-5% -$27.9K 0.01% 516
2021
Q3 		$693K Buy
5,541
+354
+7% +$42.1K 0.02% 413
2021
Q2 		$644K Buy
5,187
+1,192
+30% +$160K 0.02% 439
2021
Q1 		$610K Sell
3,995
-228
-5% -$34.5K 0.02% 413
2020
Q4 		$544K Sell
4,223
-242
-5% -$27.8K 0.02% 418
2020
Q3 		$499K Buy
4,465
+960
+27% +$87.8K 0.02% 375
2020
Q2 		$284K Buy
+3,505
New +$282K 0.01% 452

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

FDx Advisors's GH Position: Q4 2022 in Review

FDx Advisors sold out of Guardant Health (GH) in Q4 2022, closing a stake of 4,331 shares — an estimated $233K sold.

FDx Advisors first reported a position in GH in Q2 2020 and held it in 10 quarters. The position peaked at $693K in Q3 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • FDx Advisors reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • FDx Advisors sold 4,331 Guardant Health shares in Q4 2022, an estimated $233K.
  • FDx Advisors first reported a position in Guardant Health in Q2 2020 and held it in 10 quarters.
  • FDx Advisors's Guardant Health position peaked at $693K in Q3 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on FDx Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.